- Benefits of LFIA based rapid tests over laboratory testing, and rise in healthcare expenditure across the world drive the growth of the global lateral flow immunoassay based rapid test market.

The spread of the Omicron variant, which is racing through the population at a staggering speed, has brought renewed focus to the value and reliability of the at-home lateral flow test (LFT). These ...

Polymerase chain reaction (PCR) tests were the first available for spotting the coronavirus. They work by detecting the virus’s genetic material, and are very accurate. Then came rapid tests, also ...

When the coronavirus pandemic first took hold, trying to get a COVID test was like trying to get Glastonbury tickets. Hard to come by is an understatement. But now, well over a year on, a key part of ...

The Biden administration announced on Tuesday that 500 million free rapid COVID home tests would be mailed to U.S. households starting from next month, as the country battles its latest wave of the ...

A Covid-19 lateral flow test showing a negative result. Routine testing to identify those infected followed by efficient contact tracing, and supported isolation is still the most effective public ...

The COVID-19 pandemic has highlighted the need for rapid and accurate nucleic acid detection at the point of care. To meet this need, scientists from the Suzhou Institute of Biomedical Engineering and ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

The recently FDA-authorized alpha-defensin lateral flow test is a highly accurate, ten-minute test for diagnosis of periprosthetic joint infection (PJI) - a serious and costly complication of total ...